News provided by Novo Nordisk May 01, 2026, 08:04 ET With an updated formulation of semaglutide tablets and new branding, Ozempic will be available in a pill Ozempic (semaglutide) pill is the only oral GLP-1 medicine approved for both primary and secondary cardiovascular risk reduction of heart attack, stroke, and death in adults with type 2 diabetes at high risk for these events, including those with known heart disease 1 Ozempic pill will be covered by insurance for most patients with type 2 diabetes for as little as $25 and available via self-pay through NovoCare Pharmacy and major telehealth providers PLAINSBORO, N.J., May 1, 2026 /PRNewswire/ -- Novo Nordisk announced that starting Monday, May 4, Ozempic (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available for adults with type 2 diabetes in the US
Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits
The use of prescription weight loss medications has become increasingly popular as part of a comprehensive approach to long-term weight management
A doctor or nurse practitioner will assess whether a GLP-1 agonist medication is suitable for you, taking into account your individual health factors such as BMI and medical history, and will recommend the most appropriate medication for your needs
Eat and drink slowly
